RA Capital Management, L.P., Director, 10% Owner at Parabilis Medicines, Inc. (PBLS), bought 244,593 shares at $27.13 ($6.9M) on 2026-07-20, disclosed to the SEC on 2026-07-22.
Open-market purchase of $6.9M PBLS by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.13 | 98,433 | $2.7M | 38.6% |
| 2 | $27.72 | 32,987 | $914K | 13.2% |
| 3 | $27.96 | 21,696 | $607K | 8.8% |
| 4 | $29.17 | 6,504 | $190K | 2.7% |
| 5 | $30.00 | 37,723 | $1.1M | 16.4% |
| 6 | $29.77 | 47,250 |
| $1.4M |
| 20.3% |
| Total | $28.29 avg | 244,593 | $6.9M | 100% |
| Filing → |
| ARTV | BUY | 2026-07-31 | $456K | — | Filing → |
| ARTV | BUY | 2026-07-28 | $413K | — | Filing → |
| ARTV | BUY | 2026-07-23 | $58K | — | Filing → |